Commercial Credit Report for Mzhdny Mdtsky Tsnr Orbt I Krkhr Bmtr PAO

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Mzhdny Mdtsky Tsnr Orbt I Krkhr Bmtr PAO is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Mzhdny Mdtsky Tsnr Orbt I Krkhr Bmtr PAO
ul Gubkina, d. 3, k. 1, pomeshch. 1/1
Phone: +7 4956468076p:+7 4956468076	MOSCOW, 119333 Russian Federation	Ticker: GEMAGEMA

On March 4, 2022, CreditRiskMonitor.com, Inc. suppressed the FRISK® score of all publicly listed Russian and Ukrainian-based companies trading domestically due to the closure of their respective stock markets. The halt of trading in a counterparty’s securities is never a positive signal for creditors or suppliers, but especially in situations where the prices of those securities were above book value before the halt. The loss of liquidity optionality from equity markets inherently increases the bankruptcy risks for any business and dealing with businesses who have lost this financing option should be strongly scrutinized. Stock Market data is one of the essential components used in the daily calculation of the FRISK®. The omission of this data can reduce the score's effectiveness in predicting bankruptcy risk for companies trading within these markets. In addition, any analysis based on previously reported financials should be used with caution in this environment. We are continuing to monitor the Russia-Ukraine conflict and plan to reevaluate the appropriateness of the FRISK® when the affected exchanges have reopened and trading in securities resumes.

Business Summary

Mezhdunarodnyi Meditsinskiy Tsentr Obrabotki I Kriokhraneniya Biomaterialov PAO, formerly Mezhdunarodnyi Meditsinskii Tsentr Obrabotki I Kriokhraneniia Biomaterialov AO, is a Russia-based company. The Company primarily focuses on storage, processing and distribution of cord blood stem cells. As a cells bank, it offers its services to healthcare institutions, ensuring the preservation of stem cells for medical use, such as regenerative treatments. Core activities of the Company include collection, cryo-preservation and long-term storage of cord blood and other biomaterials for the healthcare industry in the Russian Federation, as well as the Commonwealth of Independent States (CIS). Mezhdunarodnyi Meditsinskiy Tsentr Obrabotki I Kriokhraneniya Biomaterialov PAO operates in compliance with industry regulations related to blood, organs, cells and other special-purpose banks, while following the safety standards.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
-	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
9/30/2024	12/31/2023	Yes	-	-	-	-

Industries

SIC Code	Description
8099	Health and allied services, not elsewhere classified

General Information

Number of Employees:	17	(As of 12/31/2023)
Outstanding Shares:	14,929,920	(As of 9/30/2024)
Stock Exchange:	MCX

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN